{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:14:35Z","timestamp":1762956875850},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,21]]},"DOI":"10.7759\/cureus.23349","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T08:33:37Z","timestamp":1647851617000},"source":"Crossref","is-referenced-by-count":2,"title":["Genetic Evaluation of Late-Onset Hypertrophic Cardiomyopathy: An Autobiographical Case Report"],"prefix":"10.7759","author":[{"given":"Simon","family":"Carlo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura F","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola A","family":"Ben\u00edtez R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma J","family":"Arciniegas-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Mart\u00ednez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Cardiomyopathy: an Overview","volume":"96","author":"Brieler J","year":"2017","unstructured":"Brieler J, Breeden MA, Tucker J. Cardiomyopathy: an Overview. Am Fam Physician. 2017, 96:640-6.","journal-title":"Am Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0209","article-title":"The diagnosis and treatment of hypertrophic cardiomyopathy","volume":"108","author":"Prinz C","year":"2011","unstructured":"Prinz C, Farr M, Hering D, Horstkotte D, Faber L. The diagnosis and treatment of hypertrophic cardiomyopathy. Dtsch Arztebl Int. 2011, 108:209-15. 10.3238\/arztebl.2011.0209","journal-title":"Dtsch Arztebl Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab424","article-title":"Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy","volume":"42","author":"Lopes LR","year":"2021","unstructured":"Lopes LR, Garcia-Hern\u00e1ndez S, Lorenzini M, et al.. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy. Eur Heart J. 2021, 42:3063-73. 10.1093\/eurheartj\/ehab424","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado D","year":"2017","unstructured":"Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017, 376:61-72. 10.1056\/NEJMra1509267","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic cardiomyopathy","volume":"121","author":"Corrado D","year":"2017","unstructured":"Corrado D, Basso C, Judge DP. Arrhythmogenic cardiomyopathy. Circ Res. 2017, 121:784-802. 10.1161\/CIRCRESAHA.117.309345","journal-title":"Circ Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.joa.2016.01.006","article-title":"The genetic background of arrhythmogenic right ventricular cardiomyopathy","volume":"32","author":"Ohno S","year":"2016","unstructured":"Ohno S. The genetic background of arrhythmogenic right ventricular cardiomyopathy. J Arrhythm. 2016, 32:398-403. 10.1016\/j.joa.2016.01.006","journal-title":"J Arrhythm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski KJ","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, et al.. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020, 581:434-43. 10.1038\/s41586-020-2308-7","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(91)90446-L","article-title":"Chromosomal assignment of the human genes coding for the major proteins of the desmosome junction, desmoglein DGI (DSG), desmocollins DGII\/III (DSC), desmoplakins DPI\/II (DSP), and plakoglobin DPIII (JUP)","volume":"10","author":"Arnemann J","year":"1991","unstructured":"Arnemann J, Spurr NK, Wheeler GN, Parker AE, Buxton RS. Chromosomal assignment of the human genes coding for the major proteins of the desmosome junction, desmoglein DGI (DSG), desmocollins DGII\/III (DSC), desmoplakins DPI\/II (DSP), and plakoglobin DPIII (JUP). Genomics. 1991, 10:640-5. 10.1016\/0888-7543(91)90446-L","journal-title":"Genomics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.10.093","article-title":"Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy","volume":"67","author":"Almomani R","year":"2016","unstructured":"Almomani R, Verhagen JM, Herkert JC, et al.. Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy. J Am Coll Cardiol. 2016, 67:515-25. 10.1016\/j.jacc.2015.10.093","journal-title":"J Am Coll Cardiol"},{"key":"ref10","unstructured":"Alpk3 alpha kinase 3 [Homo sapiens (human)] - gene - NCBI. (2021). Accessed. December 28, 2021: https:\/\/www.ncbi.nlm.nih.gov\/gene\/57538."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61176","article-title":"Phenotypic spectrum of ALPK3-related cardiomyopathy","volume":"179","author":"Al Senaidi K","year":"2019","unstructured":"Al Senaidi K, Joshi N, Al-Nabhani M, et al.. Phenotypic spectrum of ALPK3-related cardiomyopathy. Am J Med Genet A. 2019, 179:1235-40. 10.1002\/ajmg.a.61176","journal-title":"Am J Med Genet A"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00783.x","article-title":"Striate palmoplantar keratoderma resulting from desmoplakin haploinsufficiency","volume":"113","author":"Whittock NV","year":"1999","unstructured":"Whittock NV, Ashton GH, Dopping-Hepenstal PJ, et al.. Striate palmoplantar keratoderma resulting from desmoplakin haploinsufficiency. J Invest Dermatol. 1999, 113:940-6. 10.1046\/j.1523-1747.1999.00783.x","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith ED","year":"2020","unstructured":"Smith ED, Lakdawala NK, Papoutsidakis N, et al.. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020, 141:1872-84. 10.1161\/CIRCULATIONAHA.119.044934","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/82827-genetic-evaluation-of-late-onset-hypertrophic-cardiomyopathy-an-autobiographical-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:27Z","timestamp":1707507327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/82827-genetic-evaluation-of-late-onset-hypertrophic-cardiomyopathy-an-autobiographical-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.23349","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,21]]}}}